This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Bacterial Infections  • Meningitis  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

We write in response to Dr Chamberlain’s comments on our recent publication. We believe that he missed several important points that we made. Our main goal was to propagate among neurologists that leptomeningeal myelomatosis (LMM) exists and to familiarize them with its clinical and radiological manifestations and natural history. We also wanted to bring to their attention that LMM is a concomitant of very aggressive multiple myeloma that is usually resistant to systemic treatment, and irrespective of their neurological manifestations, these patients invariably succumb to their systemic disease. Our goal was not to address the feasibility of a controlled study for LMM treatment, which given the rarity of the disease, will be difficult to undertake.

In our report, we tried to emphasize that although the clinical neurological manifestations of LMM were similar to those of other neoplastic meningitides, LMM had several unique characteristics. First, LMM appears to be . . . [Full Text of this Article]

AUTHOR INFORMATION

Keith O. Schluterman, MD; Athanasios B.-T. Fassas, MD; Rudy L. Van Hemert, MD; Sami I. Harik, MD

RELATED ARTICLE

Commentary Regarding Neoplastic Meningitis Secondary to Multiple Myeloma
Marc C. Chamberlain
Arch Neurol. 2005;62(5):833.
EXTRACT | FULL TEXT